scholarly journals iNOS Interacts with Autophagy Receptor p62 and is Degraded by Autophagy in Macrophages

Cells ◽  
2019 ◽  
Vol 8 (10) ◽  
pp. 1255 ◽  
Author(s):  
Jing Wang ◽  
Ming-Yue Wu ◽  
Huanxing Su ◽  
Jinjian Lu ◽  
Xiuping Chen ◽  
...  

Nitric oxide (NO) is an important mediator of inflammation response and the production of NO has been linked to a variety of diseases, including tumors, inflammation and central nervous system diseases. In macrophages, a high level of NO is generated by iNOS during inflammatory responses triggered by cytokines or pathogens. Autophagy, a cellular bulk degradation process via lysosome, has been implicated in many disease conditions including inflammation. In this study, we have reported the previously unknown role of autophagy in regulating iNOS levels in macrophages, both under basal and Lipopolysaccharides (LPS)-induced conditions. Our data showed that iNOS levels accumulated upon autophagy inhibition and decreased upon autophagy induction. iNOS interacted and co-localized with autophagy receptor p62/SQSTM1, especially under LPS-stimulated condition in macrophages. Moreover, the immunostaining data revealed that iNOS also co-localizes with the autophagosome marker LC3 and lysosome marker LAMP1, especially under lysosomal inhibition conditions, indicating iNOS is an autophagy substrate. Finally, we showed that autophagy negatively regulated the generation of NO in macrophages, which is consistent with the changes of iNOS levels. Collectively, our study revealed a previously unknown mechanism by which autophagy regulates iNOS levels to modulate NO production during inflammation.

1996 ◽  
Vol 17 (3) ◽  
pp. 255-256
Author(s):  
F. Mari ◽  
L. Provinciali ◽  
Luigi Tesio ◽  
Chiara Gamba ◽  
Angelo Capelli ◽  
...  

Author(s):  
Rima Obeid ◽  
Andrew McCaddon ◽  
Wolfgang Herrmann

AbstractHyperhomocysteinemia (HHcy) is related to central nervous system diseases. Epidemiological studies show a positive, dose-dependent relationship between plasma total homocysteine (tHcy) concentration and neurodegenerative disease risk. tHcy is a marker of B-vitamin (folate, BClin Chem Lab Med 2007;45:1590–606.


2021 ◽  
Vol 22 (24) ◽  
pp. 13427
Author(s):  
Ivan Emmanuel Ramos-Martínez ◽  
María Carmen Rodríguez ◽  
Marco Cerbón ◽  
Juan Carlos Ramos-Martínez ◽  
Edgar Gustavo Ramos-Martínez

In several central nervous system diseases, it has been reported that inflammation may be related to the etiologic process, therefore, therapeutic strategies are being implemented to control inflammation. As the nervous system and the immune system maintain close bidirectional communication in physiological and pathological conditions, the modulation of inflammation through the cholinergic anti-inflammatory reflex has been proposed. In this review, we summarized the evidence supporting chemical stimulation with cholinergic agonists and vagus nerve stimulation as therapeutic strategies in the treatment of various central nervous system pathologies, and their effect on inflammation.


2019 ◽  
Vol 31 (11) ◽  
pp. 697-714 ◽  
Author(s):  
Jean-Philippe Auger ◽  
Marie-Odile Benoit-Biancamano ◽  
Christian Bédard ◽  
Mariela Segura ◽  
Marcelo Gottschalk

MyD88 signaling modulates the outcome of Streptococcus suis infection


Author(s):  
Wanying Liu ◽  
Xiaodan Bai ◽  
Ao Zhang ◽  
Juanjuan Huang ◽  
Shixin Xu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document